Protecting your heart starts with understanding how it works. Heart valve diseases are conditions that can disrupt the flow ...

We anticipate Livanova can bring leverage down to the target range by 2027, which would put the firm's debt at levels typical of medtech firms. Interest coverage remains well within covenants, though, ...

First dedicated leaflet modification solution to enable TAVR in patients at risk of coronary obstruction.

The FDA said to stop all use of Philips' Tack Endovascular System, which is under class I recall for user difficulties in ...

The executive director said an adjudication committee, comprised of eight architectural designers, reviewed 35 submissions for the newest design and took several months to select what artists will use ...

Valve is rumored to be releasing a new VR headset in 2025, and despite a high asking price, if it's half the product that the ...